DK0416950T3 - Medikamenter - Google Patents

Medikamenter

Info

Publication number: DK0416950T3
Authority: DK; Denmark
Prior art keywords: medications; salmeterol; inhalation; sequential; simultaneous
Prior art date: 1989-09-08

Application number

DK90309845.7T

Other languages

Danish (da)

English (en)

Inventor

James Barry Douglas Palmer

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-09-08

Filing date

1990-09-07

Publication date

1993-10-11

1989-09-08 Priority claimed from GB898920391A external-priority patent/GB8920391D0/en

1989-10-20 Priority claimed from GB898923645A external-priority patent/GB8923645D0/en

1990-09-07 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1993-10-11 Application granted granted Critical

1993-10-11 Publication of DK0416950T3 publication Critical patent/DK0416950T3/da

Links

229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000002483 medication Methods 0.000 title 1
KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 abstract 1
GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 1
229950000210 beclometasone dipropionate Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1
229960004017 salmeterol Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Thermistors And Varistors (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK90309845.7T 1989-09-08 1990-09-07 Medikamenter DK0416950T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB898920391A GB8920391D0 (en)	1989-09-08	1989-09-08	Medicaments
GB898923645A GB8923645D0 (en)	1989-10-20	1989-10-20	Medicaments

Publications (1)

Publication Number	Publication Date
DK0416950T3 true DK0416950T3 (da)	1993-10-11

Family

ID=26295893

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90309845.7T DK0416950T3 (da)	1989-09-08	1990-09-07	Medikamenter

Country Status (11)

Country	Link
EP (1)	EP0416950B1 (de)
JP (1)	JP3042866B2 (de)
AT (1)	ATE92762T1 (de)
AU (1)	AU644094B2 (de)
CA (1)	CA2024872C (de)
DE (1)	DE69002718T2 (de)
DK (1)	DK0416950T3 (de)
FR (1)	FR2651678B1 (de)
GB (1)	GB2235626B (de)
IT (1)	IT1241997B (de)
NZ (1)	NZ235222A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5270305A (en)	1989-09-08	1993-12-14	Glaxo Group Limited	Medicaments
CA2123909C (en) *	1991-12-18	2002-10-01	Christer Carl Gustav Carling	New combination of formoterol and budesonide
SK122199A3 (en) *	1997-03-18	2000-12-11	Basf Ag	Methods and compositions for modulating responsiveness to corticosteroids
US6054487A (en) *	1997-03-18	2000-04-25	Basf Aktiengesellschaft	Methods and compositions for modulating responsiveness to corticosteroids
SE9703407D0 (sv)	1997-09-19	1997-09-19	Astra Ab	New use
SE9802073D0 (sv)	1998-06-11	1998-06-11	Astra Ab	New use
IT1303692B1 (it) *	1998-11-03	2001-02-23	Chiesi Farma Spa	Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
CN1150895C (zh)	1998-11-13	2004-05-26	杰格研究股份公司	用于吸入给药的干粉
DE19921693A1 (de) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
WO2001019373A2 (en) *	1999-09-17	2001-03-22	Basf Aktiengesellschaft	Methods and compositions for modulating responsiveness to corticosteroids
GB0009617D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Respiratory combinations
FI20002216A0 (fi)	2000-10-06	2000-10-06	Orion Yhtymae Oyj	Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi)	2000-10-06	2000-10-06	Orion Yhtymae Oyj	Yhdistelmäpartikkelit
DE10202940A1 (de)	2002-01-24	2003-07-31	Sofotec Gmbh & Co Kg	Patrone für einen Pulverinhalator
US7258118B2 (en)	2002-01-24	2007-08-21	Sofotec Gmbh & Co, Kg	Pharmaceutical powder cartridge, and inhaler equipped with same
ES2312844T3 (es)	2002-12-12	2009-03-01	Nycomed Gmbh	Medicamento de combinacion de r, r-formoterol y ciclesonida.
SE527069C2 (sv)	2003-06-19	2005-12-13	Mederio Ag	Förfarande och anordning för administrering av läkemedelspulver
US20070071689A1 (en)	2003-08-06	2007-03-29	Galephar M/F	Advantageous combination for inhalation of nacystelyn and bronchodilators
EP1616592B9 (de)	2004-07-16	2011-02-02	Almirall, S.A.	Inhalator für die Abgabe von pharmzeutischen Pulver, und ein Pulverkassette zur Verwendung mit diesem Inhalator
CN101600469B (zh)	2006-12-22	2013-10-23	奥米罗有限公司	药粉吸入装置
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
PT2435025T (pt)	2009-05-29	2016-11-11	Pearl Therapeutics Inc	Administração, por via respiratória, de agentes activos
JP6454323B2 (ja)	2013-03-15	2019-01-16	パールセラピューティクス，インコーポレイテッド	粒子状結晶性材料のコンディショニングのための方法及びシステム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1571629A (en) *	1977-11-30	1980-07-16	Fisons Ltd	Pharmaceutical compositions containing beclomethasone dipropionate
GB2107715B (en) *	1981-10-19	1985-11-13	Glaxo Group Ltd	Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
ZW6584A1 (en) *	1983-04-18	1985-04-17	Glaxo Group Ltd	Phenethanolamine derivatives
FR2588474B1 (fr) *	1985-10-16	1987-11-27	Cird	Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste

1990
- 1990-09-07 NZ NZ235222A patent/NZ235222A/xx unknown
- 1990-09-07 EP EP90309845A patent/EP0416950B1/de not_active Expired - Lifetime
- 1990-09-07 JP JP2235996A patent/JP3042866B2/ja not_active Expired - Fee Related
- 1990-09-07 DE DE90309845T patent/DE69002718T2/de not_active Expired - Fee Related
- 1990-09-07 DK DK90309845.7T patent/DK0416950T3/da active
- 1990-09-07 IT IT48261A patent/IT1241997B/it active IP Right Grant
- 1990-09-07 FR FR909011141A patent/FR2651678B1/fr not_active Expired - Fee Related
- 1990-09-07 GB GB9019651A patent/GB2235626B/en not_active Expired - Fee Related
- 1990-09-07 AT AT90309845T patent/ATE92762T1/de not_active IP Right Cessation
- 1990-09-07 CA CA002024872A patent/CA2024872C/en not_active Expired - Lifetime
- 1990-09-07 AU AU62260/90A patent/AU644094B2/en not_active Ceased

Also Published As

Publication number	Publication date
DE69002718D1 (de)	1993-09-16
GB9019651D0 (en)	1990-10-24
FR2651678A1 (fr)	1991-03-15
JP3042866B2 (ja)	2000-05-22
GB2235626A (en)	1991-03-13
EP0416950B1 (de)	1993-08-11
EP0416950A1 (de)	1991-03-13
NZ235222A (en)	1992-11-25
ATE92762T1 (de)	1993-08-15
IT1241997B (it)	1994-02-02
CA2024872A1 (en)	1991-03-09
IT9048261A0 (it)	1990-09-07
IT9048261A1 (it)	1992-03-07
AU644094B2 (en)	1993-12-02
DE69002718T2 (de)	1993-12-23
FR2651678B1 (fr)	1992-04-30
CA2024872C (en)	2002-07-09
GB2235626B (en)	1994-02-09
AU6226090A (en)	1991-03-14
JPH03167119A (ja)	1991-07-19

Publication	Publication Date	Title
DE19975040I2 (de)	2006-07-13	Medikamente enthaltend Salmeterol und Fluticason
AU644094B2 (en)	1993-12-02	Medicaments
AU762481C (en)	2004-08-19	Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
KR930702022A (ko)	1993-09-08	인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
CA2123909A1 (en)	1993-06-24	New combination of formoterol and budesonide
GEP20002253B (en)	2000-10-25	Pharmaceutical Aerosol Formulation, Proportioning Inhalator and Method for Treatment of Respiratory Diseases
DE69127470D1 (de)	1997-10-02	Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
BR0010498A (pt)	2002-02-26	Composições modernas de medicamentos à base de compostos anticolinergicamente ativos e beta-miméticos
DE69918961D1 (de)	2004-09-02	Verbesserte inhalationspräparate
MY111155A (en)	1999-09-30	Medicaments
EP0384302A3 (de)	1992-01-02	Verwendung von Ubenimex zur Hestellung eines Medikaments zur Behandlung des myelodysplastischen Syndroms
JPS6438027A (en)	1989-02-08	Remedy for cancer
RU93003454A (ru)	1996-11-10	Лекарственный препарат